The Genetics Podcast
The Genetics Podcast
Sano Genetics
EP 230: From short reads to long reads in clinical genomics with Anna Lindstrand of Karolinska Institute
39 minutes Posted Mar 12, 2026 at 12:00 pm.
Intro to The Genetics Podcast00:59 Welcome to Anna01:34 Choosing between whole genome, exome, panels, and long-read sequencing in clinical practice04:05 Evaluating long-read sequencing in the clinic 06:37 What long-read sequencing adds to diagnostic yield09:15 The role of RNA sequencing, proteomics, and methylation profiling as complementary tools in clinical genomics13:07 Building a coordinated national infrastructure for clinical genomics and rare disease research in Sweden18:20 The shift toward precision therapeutics and new standards for clinical actionability23:18 Using national genomic data and registries to make Sweden trial-ready for precision therapies27:01 Moving beyond monogenic models to capture polygenic and borderline signals in clinical genomics30:44 Genomics for prevention including adult screening and pharmacogenomics36:23 Anna’s research priorities for the next phase of genomic medicine and structural variant discovery38:32 Closing remarksFind out more:Long-read sequencing studyMoving beyond monogenic disease paperPlease consider rating and reviewing us on your chosen podcast listening platform!
0:00
39:40
Download MP3
Show notes
This week on The Genetics Podcast, Patrick is joined by Dr. Anna Lindstrand, Professor and Consultant in Clinical Genetics and Genomics at the Karolinska Institute. They discuss how Sweden has scaled whole genome sequencing as a first-line test for rare disease, what long-read sequencing adds to clinical diagnostics, how national genomic infrastructure can accelerate translation into precision medicine, and where prevention and adult genomic screening may fit into the future of healthcare.Show Notes0:00 Intro to The Genetics Podcast00:59 Welcome to Anna01:34 Choosing between whole genome, exome, panels, and long-read sequencing in clinical practice04:05 Evaluating long-read sequencing in the clinic 06:37 What long-read sequencing adds to diagnostic yield09:15 The role of RNA sequencing, proteomics, and methylation profiling as complementary tools in clinical genomics13:07 Building a coordinated national infrastructure for clinical genomics and rare disease research in Sweden18:20 The shift toward precision therapeutics and new standards for clinical actionability23:18 Using national genomic data and registries to make Sweden trial-ready for precision therapies27:01 Moving beyond monogenic models to capture polygenic and borderline signals in clinical genomics30:44 Genomics for prevention including adult screening and pharmacogenomics36:23 Anna’s research priorities for the next phase of genomic medicine and structural variant discovery38:32 Closing remarksFind out more:Long-read sequencing studyMoving beyond monogenic disease paperPlease consider rating and reviewing us on your chosen podcast listening platform!